Research
Molecular
Conventional antihyperglycemic medications have minimal effect on lowering cardiovascular risk in T2DM patients.
Practitioners should be aware that conventional medications may not effectively reduce cardiovascular risk in T2DM patients.
StrongSupportsmedium confidence
However, conventional antihyperglycemic medications seem to have minimal effect on lowering CV risk despite achieving excellent reductions in glycated hemoglobin A1c.
Why this rating
The claim is based on a comprehensive review of existing literature.
Source
Sodium–Glucose Cotransporter-2 Inhibition in Type 2 Diabetes Mellitus
Rinkoo Dalan · Cardiology in Review · 2018
DOI 10.1097/crd.0000000000000201
reviewCited 5×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Molecular
- QRISK decreased markedly after weight loss from 18.9 ± 2.2% to 11.2 ± 1.6%, p < 0.0001.Strong
- Normalization of 10-year cardiovascular risk and heart age is possible after substantial dietary weight loss and remission of T2DM.Strong
- The Low-Fat Plus diet resulted in a greater reduction in total cholesterol compared to the Low-Fat diet, with changes of -0.46 mmol/L (-17.6 mg/dL) versus -0.24 mmol/L (-9.2 mg/dL) respectively (P = 0.01).Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →